相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis
Reinhard Stauder et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
Fabio Efficace et al.
LEUKEMIA (2020)
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group
Ursula Rochau et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Malnutrition in Older Patients With Hematological Malignancies at Initial Diagnosis - Association With Impairments in Health Status, Systemic Inflammation and Adverse Outcome
Reinhard Stauder et al.
HEMASPHERE (2020)
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes
Titas Banerjee et al.
BLOOD REVIEWS (2019)
The inflammatory cytokine profile of myelodysplastic syndromes A meta-analysis
Xin Shi et al.
MEDICINE (2019)
Change in Quality of Life after a Cancer Diagnosis among a Nationally Representative Cohort of Older Adults in the US
Rebecca M. Schwartz et al.
CANCER INVESTIGATION (2019)
Associations between inflammatory and neurological markers with quality of life and well-being in older adults
Jamie L. Tait et al.
EXPERIMENTAL GERONTOLOGY (2019)
Association of anemia with health-related quality of life and survival: a large population-based cohort study
Hanneke J. C. M. Wouters et al.
HAEMATOLOGICA (2019)
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
Reinhard Stauder et al.
LEUKEMIA (2018)
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes
Kathryn S. Ivy et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes
Thomas Cluzeau et al.
HAEMATOLOGICA (2017)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
U. Platzbecker et al.
LEUKEMIA (2017)
Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes
Thomas Cluzeau et al.
HAEMATOLOGICA (2017)
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
Louise de Swart et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Anemia as the Main Manifestation of Myelodysplastic Syndromes
Valeria Santini
SEMINARS IN HEMATOLOGY (2015)
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes
Fabio Efficace et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Cohort Profile: LifeLines, a three-generation cohort study and biobank
Salome Scholtens et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Representativeness of the LifeLines Cohort Study
Bart Klijs et al.
PLOS ONE (2015)
Chronic inflammation and quality of life in older adults: a cross-sectional study using biomarkers to predict emotional and relational outcomes
Alexandra C. H. Nowakowski
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati et al.
BLOOD (2013)
Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: Results from a randomized clinical trial
Dennis A. Revicki et al.
LEUKEMIA RESEARCH (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
Wolfgang Linden et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Uwe Platzbecker et al.
LEUKEMIA RESEARCH (2012)
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
Pierre Fenaux et al.
BLOOD (2011)
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
Matteo G. Della Porta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Poorer self-rated health is associated with elevated inflammatory markers among older adults
Lisa M. Christian et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
Donna Rowen et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2009)
Mechanism of action of lenalidomide in hematological malignancies
Venumadhav Kotla et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Impact of Cancer on Health-Related Quality of Life of Older Americans
Bryce B. Reeve et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Fatigue in a Representative Population of Older Persons and Its Association With Functional Impairment, Functional Limitation, and Disability
Sonja Vestergaard et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2009)
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II
Emily Cox et al.
VALUE IN HEALTH (2009)
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): Results of a large internet-based survey
David P. Steensma et al.
LEUKEMIA RESEARCH (2008)
Universal risk factors for multifactorial diseases - LifeLines: a three-generation population-based study
Ronald P. Stolk et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2008)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Self-rated health showed a graded association with frequently used biomarkers in a large population sample
M Jylhä et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Estimating the association between SF-12 responses and EQ-5D utility values by response mapping
AM Gray et al.
MEDICAL DECISION MAKING (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome
EN Oliva et al.
LEUKEMIA RESEARCH (2005)
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
CA Meyers et al.
CANCER (2005)
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes:: a randomized, controlled trial
N Casadevall et al.
BLOOD (2004)
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure
Y Okura et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
AJG Jansen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life
E Hellström-Lindberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
分享论文
